Clincosm LogoSign in Get a demo

Bladder Cancer

Showing NaN - NaN of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial in Baltimore (ERAS Protocol, Standard of Care)

Not yet recruiting
  • Bladder Cancer
  • ERAS Protocol
  • Standard of Care
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jun 14, 2023

Bladder Cancer Trial in Washington, Baltimore (Prostate capsule-sparing radical cystectomy, Nerve sparing radical cystectomy)

Not yet recruiting
  • Bladder Cancer
  • Prostate capsule-sparing radical cystectomy
  • Nerve sparing radical cystectomy
  • Washington, District of Columbia
  • +1 more
Mar 28, 2023

Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

Not yet recruiting
  • Bladder Cancer
  • Scottsdale, Arizona
  • +241 more
Feb 9, 2023

Gender Related Coping and Survivorship for Genitourinary Cancers

Recruiting
  • Bladder Cancer
  • Additional Education
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jan 23, 2023

Breast Cancer, Prostate Cancer, Melanoma (Skin) Trial in Baltimore (Written Weight Loss Material, Weight Loss App, Behavioral

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Written Weight Loss Material
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins ProHealth
Jan 19, 2023

Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Durvalumab (Cohort 1-3)
  • +7 more
  • Phoenix, Arizona
  • +10 more
Jan 11, 2023

High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab

Not yet recruiting
  • High Grade Urothelial Carcinoma
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jan 5, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)

    Completed
    Has Results
    • Urothelial Carcinoma
    • Bladder Cancer
    • Phoenix, Arizona
    • +27 more
    Sep 16, 2022

    Biomarkers in Subjects With Untreated Solid Tumors

    Completed
    • Breast Cancer
    • +12 more
    • Blood Sample Collection
    • Phoenix, Arizona
    • +118 more
    Aug 31, 2022

    Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Metastatic Cancer
    • +9 more
    • Mobile, Alabama
    • +19 more
    Aug 1, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Bladder Cancer Trial in Canada, United States (therapeutic conventional surgery, therapeutic standard lymphadenectomy,

    Active, not recruiting
    • Bladder Cancer
    • therapeutic conventional surgery
    • +2 more
    • Los Angeles, California
    • +34 more
    Jul 20, 2022

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

    Recruiting
    • Bladder Cancer
    • +2 more
    • Tucson, Arizona
    • +76 more
    Jul 13, 2022

    Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

    Completed
    Has Results
    • Bladder Cancer
    • Urothelial Carcinoma
    • Birmingham, Alabama
    • +34 more
    Jul 7, 2022

    Bladder Cancer Trial in Indianapolis, Baltimore, Rockledge (Dovitinib)

    Terminated
    Has Results
    • Bladder Cancer
    • Indianapolis, Indiana
    • +2 more
    Jul 7, 2022

    Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

    Recruiting
    • Small Cell Neuroendocrine Carcinoma of Bladder
    • +2 more
    • Washington, District of Columbia
    • +1 more
    Jun 27, 2022

    Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

    Recruiting
    • Ovarian Cancer
    • +10 more
    • West Hollywood, California
    • +27 more
    Jun 27, 2022

    Bladder Cancer Trial in Canada, United States (drug, radiation, procedure)

    Completed
    Has Results
    • Bladder Cancer
    • induction cisplatin
    • +13 more
    • Atlanta, Georgia
    • +10 more
    May 23, 2022

    Bladder Cancer Trial in United States (cisplatin, 5-fluorouracil, Mitomycin)

    Active, not recruiting
    Has Results
    • Bladder Cancer
    • Atlanta, Georgia
    • +12 more
    Mar 28, 2022

    Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)

    Active, not recruiting
    • Bladder Cancer
    • +3 more
    • IPI-549 (eganelisib)
    • +2 more
    • Fort Wayne, Indiana
    • +28 more
    Apr 1, 2022

    Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)

    Active, not recruiting
    • Urothelial Carcinoma
    • +3 more
    • Biospecimen Collection
    • Los Angeles, California
    • +7 more
    Feb 14, 2022

    Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

    Completed
    • Prostate Cancer
    • +6 more
    • MGA271
    • Los Angeles, California
    • +11 more
    Feb 4, 2022

    Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

    Recruiting
    • Urothelial Carcinoma
    • +20 more
    • Gilbert, Arizona
    • +9 more
    Feb 3, 2022